Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in Wake-up Ischaemic Stroke Trial
ISRCTN10601890Phase 3Completed
- Sponsor
- University Hospital of North Norway
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of tenecteplase in brain infarction (2 arms), sponsored by University Hospital of North Norway. Primary endpoint: Functional outcome at 3 months. Started Jul 2017; status: completed.
02
Drugs
tenecteplase
03
Conditions
brain infarction
Beyond the preview
Go deeper on ISRCTN10601890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10601890.